My Cart

Close

CardioMetabolic Profile (Insulin, HsCRP, HbA1c, TG, CH, LDL, HDL, VLDL)

NORDIC LABORATORIES

R 3,340.00

"JOINCIRCLES enables you to own your own medical data. When you receive your biochemistry results, we strongly advise that you contact one or more of healthcare practitioners listed under our "Practitioner Circle' who have been trained to interpret these tests. Once you have a plan from your practitioner, you can come back and shop your personalised daily nutrition, environment and lifestyle choices. As the medical director, I'm available to help you chose the right test and/or practitioner for your needs". Dr Heidi

This CardioMetabolic Profile blood spot test allows early detection of major markers associated with metabolic/insulin resistance syndrome.

Benefits | Features

  • Use as a screening profile to help choose the most appropriate treatment recommendations to reduce the overall risk of type 2 diabetes mellitus (DM2) and cardiovascular disease (CVD)
  • Regular testing can be used to assess risk of DM2 and to monitor people with DM2
  • Testing + clinical assessment can be reliable, predictive tools for determining overall cardiometabolic risk

More info

The incidence of CVD, obesity and DM2 is rising at an alarming rate. CVD is the leading cause of mortality for both men and women in the developed world; obesity, insulin resistance and DM2 significantly predispose someone to develop CVD, yet these conditions are potentially avoidable.

If we are to make an impact on the serious health and economic consequences of these diseases, we need to identify risk early enough for people to make lifestyle changes or seek medical help to avoid becoming a part of the rising statistics.

Cardiometabolic risk has been defined as 'the cluster of modifiable risk factors and markers that identify individuals at increased risk for cardiovascular disease (myocardial infarction, stroke, peripheral arterial disease) and type 2 diabetes.'

The National Cholesterol Education Program (NCEP)’s Adult Treatment Panel III (ATP III) has identified the metabolic syndrome/insulin resistance syndrome as a major risk factor for DM2 and CVD. NCEP-ATP III criteria for identifying metabolic syndrome include:

  • Hypertension/elevated blood pressure
  • Abdominal obesity
  • Atherogenic dyslipidemia (low HDL cholesterol, elevated triglycerides, elevated LDL cholesterol)
  • Prothrombotic/pro-inflammatory state
  • Insulin resistance/glucose intolerance

Who would benefit from this test?

ANYONE WITH THE FOLLOWING SYMPTOMS AND/OR CONDITIONS:
  • Obesity
  • Type 2 diabetes
  • High blood pressure
  • Abnormal cholesterol levels
  • Heart disease
  • Polycystic ovary syndrome
  • Impaired fasting blood sugar
  • Impaired glucose tolerance
  • Type 2 diabetes
  • Heart disease
  • Kidney damage 

Pair with these DNA Tests

Tests for

Cardio-metabolic risk, specifically by testing for major indicators of metabolic/insulin resistance syndrome

Test type

  • Cardiovascular
  • Metabolic support
  • Metabolic function

Test analytes

  • High Sensitivity C-Reactive Protein (hs-CRP) 
  • Total cholesterol
  • Low-density lipoprotein (LDL) cholesterol
  • Very low-density lipoprotein (VLDL) cholesterol
  • High-density lipoprotein (HDL) cholesterol
  • Fasting insulin
  • Hemoglobin A1c (HbA1c)
  • Fasting Triglycerides
  • Test sample report

    Sample required

    Bloodspot

    Processing time

    About 2-3 weeks

    Lab's name for test

    CardioMetabolic Profile I (Insulin, HsCRP, HbA1c, TG, CH, LDL, HDL, VLDL)

    Hello You!

    Join our mailing list